BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25828893)

  • 1. c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated Leukemias.
    Muvarak N; Kelley S; Robert C; Baer MR; Perrotti D; Gambacorti-Passerini C; Civin C; Scheibner K; Rassool FV
    Mol Cancer Res; 2015 Apr; 13(4):699-712. PubMed ID: 25828893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias.
    Tobin LA; Robert C; Rapoport AP; Gojo I; Baer MR; Tomkinson AE; Rassool FV
    Oncogene; 2013 Apr; 32(14):1784-93. PubMed ID: 22641215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative NHEJ Pathway Components Are Therapeutic Targets in High-Risk Neuroblastoma.
    Newman EA; Lu F; Bashllari D; Wang L; Opipari AW; Castle VP
    Mol Cancer Res; 2015 Mar; 13(3):470-82. PubMed ID: 25563294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked contribution of alternative end-joining to chromosome-translocation-formation by stochastically induced DNA double-strand-breaks in G2-phase human cells.
    Soni A; Siemann M; Pantelias GE; Iliakis G
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():2-8. PubMed ID: 26520366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks.
    Sallmyr A; Tomkinson AE; Rassool FV
    Blood; 2008 Aug; 112(4):1413-23. PubMed ID: 18524993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common and unique genetic interactions of the poly(ADP-ribose) polymerases PARP1 and PARP2 with DNA double-strand break repair pathways.
    Ghosh R; Roy S; Kamyab J; Danzter F; Franco S
    DNA Repair (Amst); 2016 Sep; 45():56-62. PubMed ID: 27373144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cells expressing FLT3/ITD mutations exhibit elevated repair errors generated through alternative NHEJ pathways: implications for genomic instability and therapy.
    Fan J; Li L; Small D; Rassool F
    Blood; 2010 Dec; 116(24):5298-305. PubMed ID: 20807885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9-Induced Double-Strand Break Repair in Arabidopsis Nonhomologous End-Joining Mutants.
    Shen H; Strunks GD; Klemann BJ; Hooykaas PJ; de Pater S
    G3 (Bethesda); 2017 Jan; 7(1):193-202. PubMed ID: 27866150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative NHEJ pathway proteins as components of MYCN oncogenic activity in human neural crest stem cell differentiation: implications for neuroblastoma initiation.
    Newman EA; Chukkapalli S; Bashllari D; Thomas TT; Van Noord RA; Lawlor ER; Hoenerhoff MJ; Opipari AW; Opipari VP
    Cell Death Dis; 2017 Dec; 8(12):3208. PubMed ID: 29238067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCR/ABL stimulates WRN to promote survival and genomic instability.
    Slupianek A; Poplawski T; Jozwiakowski SK; Cramer K; Pytel D; Stoczynska E; Nowicki MO; Blasiak J; Skorski T
    Cancer Res; 2011 Feb; 71(3):842-51. PubMed ID: 21123451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere-Internal Double-Strand Breaks Are Repaired by Homologous Recombination and PARP1/Lig3-Dependent End-Joining.
    Doksani Y; de Lange T
    Cell Rep; 2016 Nov; 17(6):1646-1656. PubMed ID: 27806302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement for Parp-1 and DNA ligases 1 or 3 but not of Xrcc1 in chromosomal translocation formation by backup end joining.
    Soni A; Siemann M; Grabos M; Murmann T; Pantelias GE; Iliakis G
    Nucleic Acids Res; 2014 Jun; 42(10):6380-92. PubMed ID: 24748665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pim kinase inhibitor co-treatment decreases alternative non-homologous end-joining DNA repair and genomic instability induced by topoisomerase 2 inhibitors in cells with FLT3 internal tandem duplication.
    Scarpa M; Kapoor S; Tvedte ES; Doshi KA; Zou YS; Singh P; Lee JK; Chatterjee A; Ali MKM; Bromley RE; Hotopp JCD; Rassool FV; Baer MR
    Oncotarget; 2021 Aug; 12(18):1763-1779. PubMed ID: 34504649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting abnormal DNA repair in therapy-resistant breast cancers.
    Tobin LA; Robert C; Nagaria P; Chumsri S; Twaddell W; Ioffe OB; Greco GE; Brodie AH; Tomkinson AE; Rassool FV
    Mol Cancer Res; 2012 Jan; 10(1):96-107. PubMed ID: 22112941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and function of the DNA ligases encoded by the mammalian LIG3 gene.
    Tomkinson AE; Sallmyr A
    Gene; 2013 Dec; 531(2):150-7. PubMed ID: 24013086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasiveness.
    Richter C; Marquardt S; Li F; Spitschak A; Murr N; Edelhäuser BAH; Iliakis G; Pützer BM; Logotheti S
    J Exp Clin Cancer Res; 2019 Jul; 38(1):292. PubMed ID: 31287003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation.
    Simsek D; Brunet E; Wong SY; Katyal S; Gao Y; McKinnon PJ; Lou J; Zhang L; Li J; Rebar EJ; Gregory PD; Holmes MC; Jasin M
    PLoS Genet; 2011 Jun; 7(6):e1002080. PubMed ID: 21655080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parp1-XRCC1 and the repair of DNA double strand breaks in mouse round spermatids.
    Ahmed EA; de Boer P; Philippens ME; Kal HB; de Rooij DG
    Mutat Res; 2010 Jan; 683(1-2):84-90. PubMed ID: 19887075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways.
    Wang M; Wu W; Wu W; Rosidi B; Zhang L; Wang H; Iliakis G
    Nucleic Acids Res; 2006; 34(21):6170-82. PubMed ID: 17088286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of DNA double-strand break repair pathways in diffuse large B cell lymphoma.
    Gopalakrishnan V; Dahal S; Radha G; Sharma S; Raghavan SC; Choudhary B
    Mol Carcinog; 2019 Feb; 58(2):219-233. PubMed ID: 30298948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.